Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT05549960
Eligibility Criteria:
Inclusion Criteria:
* Histologic diagnosis of pancreatic ductal adenocarcinoma (stage III or IV);
* Inoperable neuroendocrine tumor;
* Pancreatic metastasis from renal clear cell cancer;
* Stable situation or progression after chemotherapeutic treatment;
* Age \>18 years;
* Acquisition of signed Informed Consent;
* Performance status 0-1-2 (ECOG).
Exclusion Criteria:
* Absolute contraindications to general anaesthesia or deep sedation;
* Absence of suitable ultrasound acoustic window for the procedure;
* Known bleeding disorders that cannot be sufficiently corrected with clotting factors or fresh frozen plasma (FFP);
* Use of anticoagulants that cannot be discontinued;
* International normalized ratio (INR) \>1.5 or platelet count \<50,000;
* Pregnancy or lactation;
* Inability to sign informed consent;
* Other concomitant neoplastic diseases.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05549960
Study Brief:
Protocol Section:
NCT05549960